ISTA PHARMACEUTICALS INC Stock-Based Compensation
ISTA PHARMACEUTICALS INC reported Stock-Based Compensation of $1.53 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $1.53M, a 50.84% increase year-over-year.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $1.41M, a 46.52% increase year-over-year.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $1.09M, a 6.62% increase year-over-year.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was $754.00K.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $4.28M, a 10.75% increase from fiscal 2010.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $3.86M, a 3.32% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $3.74M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $1.53M 10-Q · filed 2012-05-04 | $2.94M derived: sum of 2 quarters · filed 2012-05-04 | $4.04M derived: sum of 3 quarters · filed 2012-05-04 | $4.79M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.51M derived: sum of 2 quarters · filed 2012-02-27 | $3.26M derived: sum of 3 quarters · filed 2012-02-27 | $4.28M 10-K · filed 2012-02-27 |
| 2011-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.85M derived: sum of 2 quarters · filed 2011-11-07 | $2.87M 10-Q · filed 2011-11-07 | $3.83M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $754.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $1.77M 10-Q · filed 2011-08-01 | $2.73M derived: sum of 3 quarters · filed 2012-05-04 | $3.76M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $1.02M 10-Q · filed 2012-05-04 | $1.98M derived: sum of 2 quarters · filed 2012-05-04 | $3.01M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $963.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $1.99M derived: sum of 2 quarters · filed 2012-02-27 | $3.86M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $2.90M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $1.87M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $3.74M 10-K · filed 2012-02-27 |